Novozymes A/S B buy RudolfL
Start price
26.01.20
/
50%
€46.87
Target price
13.08.20
€53.00
Performance (%)
5.33%
End price
13.08.20
€49.37
Summary
This prediction ended on 13.08.20 with a price of €49.37. With a performance of 5.33%, the BUY prediction by RudolfL for Novozymes A/S B closed with a slight gain. Dividends of €0.70 are taken into consideration when calculating the performance. RudolfL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novozymes A/S B | 0.884% | 0.884% | -0.073% | 15.552% |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% | 72.985% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% | 115.777% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% | 49.561% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% | 69.577% |
According to RudolfL what are the pros and cons of Novozymes A/S B for the foreseeable future?
Pros
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
ROE higher than 15% per year
Cons
Revenue decline/stagnation expected
Comments by RudolfL for this prediction
In the thread Novozymes A/s Nam. B diskutieren
In the thread Trading Novozymes A/s Nam. B
Stopped prediction by RudolfL for Novozymes A/S B
Novozymes A/S B
Start price
Target price
Perf. (%)
€55.52
11.09.20
11.09.20
€63.00
04.11.21
04.11.21
18.70%
05.11.21
05.11.21
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
Revenue decline/stagnation expected
